Grow Pharma

MYSTIC Program in Europe and the United States (19972004). Diag Microbiol Infect Dis., 2005; 53: 257–264. 14. GOOTZ, T.D. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance. Biochemic Pharma., 2006; 71: 1073-1084. 15. HERNANDEZ-ALES, S.; CONEJO, M.; PASCUAL, A.; TOMAS, J.M.; BENEDI, V.J.; MARTINEZ-MARTINEZ, L. Porin expression in clinical isolates of Klebsiella pneumoniae. J Microbiol., 1999; 145: 673-679. 16. JACOBY,…

young and small compared to its competition. This fact accounts for the sharp contrast between the company’s assets and its top competitors’ assets. Amylin Pharmaceuticals, Inc. Financial Analysis Report 14 Growth Rate Amylin continues to grow as a leader in diabetes research and development. In October 2008, the American Diabetic Association (ADA) and its European counterpart, the EASD, updated guidelines regarding treatment for diabetes establishing BYETTA® (exenatide) as…

bioavailability of solid dispersions are not expected to change significantly during the scale up. For this reason, the popularity of the solid dispersion system to solve difficult bioavailability issues with respect to poorly water-soluble drugs will grow rapidly. Because the dosage form can be developed and prepared using small amounts 1064 / Journal of Pharmaceutical Sciences Vol. 88, No. 10, October 1999 of drug substances in early stages of the drug development process, the system…

any given day, these are the brands the average consumer interacts with the most. our hands click their keyboard keys. our information is fed through their systems. We use their infrastructures day in and day out. and as these brands continue to grow in value and stature, reshaping our lives, it is only inevitable that we are reshaping them in turn. iBm watson (Credit: IBM) THE HumAN TOuCH “Every designer’s ambition is to make technology disappear, so you use it but you…

years will build on the cooperation between the two organizations that began in 1998. TABLE OF CONTENTS Bayer Sustainable Development Report 2009 11 Our challenges Better diagnosis of Alzheimer’s disease In November 2009, Bayer Schering Pharma announced the start of a Phase iii study to investigate the efficacy and safety of florbetaben in the identification of beta amyloid plaques in the brain using positron emission tomography (pet). The plaques are a pathological feature…

formado pelos programas CarreirAché, Trainee e A Hora é Agora. Personnel management at Aché is focused on identifying and developing talent, encouraging and stimulating the enhancement of skills and the acquisition of the new knowledge necessary to grow the business and the professionals in it. The company has its own model for developing and valuing the Aché Generation. This is based on three pillars: Management Development, to guarantee linkage between strategy and execution.…

aging population and high expectations, consumption of medicines in general will continue to increase significantly in coming decades, but due to economic constraints and lack of true innovation in many therapeutic areas, consumption is expected to grow mainly in generic drugs. It is important for Portugal to recognize the strategic importance of a strong and modern Pharmaceutical industry, internationally competitive, allowing the country to be not only less dependent on imported…

pregnancy may not be a solution to the pregnant adolescent because maternity may bring maturity but may, on the other hand, contribute to aggravate the existing problems. Besides this maturing factor and the child’s birth, responsibilities grow up and are collected by relatives and society. The consequences of early pregnancy have various effects on the adolescent’s life, and may vary from school dropout to an intemperate life including the use of illegal…

their price targets for PT, maintaining their recommendations unchanged. de - Sonaecom guarantee maintains greater strategy to garantir maior eficiência; lucros crescem no semestre, atingindo os 19,6 milhões de euros. efficiency; profits grow in the first half of 2010, reaching 19.6 million euros. - Zon «só por aquisição» poderia atingir - Zon could only reach revenue target of meta de receitas de mil milhões de euros; lucros diminuem 21,2 por cento no semestre (aumento de…

the functions are substantially different: for smaller values of x, the functions I and II reach high values of y; the behavior is different in the functions IV and V, where the values of y grow more slowly when x is increased. The function V is a logarithmic equation and one of its main characteristic is to grow y slowly as x increases, tending to stabilize at infinity. Figure 2: illustrates the behavior of different mathematical functions. Figure 3: illustrates the influence of…